Latest Revenue News

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.

Deterra Royalties delivered a 5% increase in statutory net profit to $164.2 million for FY26, underpinned by record Mining Area C volumes and strategic asset sales. The company declared a fully franked final dividend of 10.8 cents, maintaining a 75% payout ratio, while advancing the Thacker Pass lithium project on schedule for late 2027 production.

SRG Global reported record FY26 results driven by strong operational delivery, strategic acquisition of TAMS, and enhanced sustainability governance. The company upgraded its FY27 EBITDA guidance to $195–205 million, supported by a $5.1 billion work in hand and $11.5 billion opportunity pipeline.

Macmahon Holdings delivered a tenth consecutive year of growth with revenue up 7.9% to $2.6 billion and net profit after tax soaring 36.8% to $101.1 million, underpinned by strong contract wins and operational discipline.

Mercury NZ Limited posted a staggering 32,000% surge in net profit for FY26 despite an 8% revenue dip, underpinned by strong renewable generation and disciplined cost control.

Vector Limited (NZX:VCT) posted a 55% jump in net profit to $240 million for FY2026, driven by a 20% rise in adjusted EBITDA and a record $544 million capital investment in Auckland’s electricity network.

Scott Technology has locked in NZ$20 million worth of new Materials Handling & Logistics contracts across North America and Europe, reinforcing its Destination 2030 growth strategy and building on strong FY26 momentum.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.

Mesoblast has treated 350 patients in its pivotal Phase 3 trial for rexlemestrocel-L, targeting chronic low back pain linked to degenerative disc disease, setting the stage for top-line results in mid-2027.

Synertec Corporation Limited (ASX:SOP) reported a 19% revenue increase in FY26 alongside its first net operating cash inflow since FY19. The company raised approximately A$6 million through an institutional placement to support working capital and growth initiatives while reaffirming FY27 revenue guidance.

GR Engineering Services has locked in a $275 million EPC contract for the Yitirrti Copper-Silver-Zinc Project, reinforcing its position as a leading Australian minerals processing contractor.

Andromeda Metals is targeting $3 million through a Share Purchase Plan to fund the next phase of its High Purity Alumina project, including pilot plant optimisation and a Pre-feasibility Study.